VOR BIOPHARMA INC (VOR) Forecast, Price Target & Analyst Ratings

NASDAQ:VORUS9290332074

Current stock price

16.59 USD
+1.62 (+10.82%)
At close:
16.59 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for VOR BIOPHARMA INC (VOR).

Forecast Snapshot

Consensus Price Target

Price Target
$38.38
+ 131.33% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
May 12, 2026
Period
Q1 / 2026
EPS Estimate
-$0.77
Revenue Estimate

ChartMill Buy Consensus

Rating
84.62%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$38.38
Upside
+ 131.33%
From current price of $16.59 to mean target of $38.38, Based on 13 analyst forecasts
Low
$15.15
Median
$40.80
High
$52.50

Price Target Revisions

1 Month
-2.69%
3 Months
3.37%

Price Target Summary

13 Wall Street analysts provided a forecast for the next 12 months for VOR. The average price target is 38.38 USD. This implies a price increase of 131.33% is expected in the next year compared to the current price of 16.59.
The average price target has been revised upward by 3.37% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

VOR Current Analyst RatingVOR Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

VOR Historical Analyst RatingsVOR Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
84.62%
VOR was analyzed by 13 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about VOR.
In the previous month the buy percentage consensus was at a similar level.
VOR was analyzed by 13 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-04-15HC Wainwright & Co.Maintains Buy -> Buy
2026-03-31WedbushMaintains Neutral -> Neutral
2026-03-30JefferiesInitiate Buy
2026-03-19Wells FargoInitiate Overweight
2026-01-09CitigroupInitiate Buy
2025-12-19JP MorganMaintains Overweight -> Overweight
2025-12-17TD CowenInitiate Buy
2025-12-09JP MorganInitiate Overweight
2025-11-14HC Wainwright & Co.Maintains Buy -> Buy
2025-10-29HC Wainwright & Co.Maintains Buy -> Buy
2025-10-15BairdUpgrade Neutral -> Outperform
2025-08-14HC Wainwright & Co.Reiterate Buy -> Buy
2025-06-30HC Wainwright & Co.Upgrade Neutral -> Buy
2025-06-27BairdMaintains Neutral -> Neutral
2025-06-26WedbushReiterate Neutral -> Neutral
2025-05-09JMP SecuritiesDowngrade Market Outperform -> Market Perform
2025-05-09HC Wainwright & Co.Downgrade Buy -> Neutral
2025-03-21OppenheimerReiterate Outperform -> Outperform
2025-03-21StifelMaintains Buy -> Buy
2025-03-21HC Wainwright & Co.Maintains Buy -> Buy
2024-12-10JMP SecuritiesReiterate Market Outperform -> Market Outperform
2024-12-10HC Wainwright & Co.Reiterate Buy -> Buy
2024-11-08BairdMaintains Outperform -> Outperform
2024-11-08HC Wainwright & Co.Reiterate Buy -> Buy
2024-09-06JMP SecuritiesReiterate Market Outperform -> Market Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 12, 2026
Period
Q1 / 2026
EPS Estimate
-$0.77
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
85.22%
Number of Analysts
10

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
23.60%
EPS (3 Months)
29.78%

Next Earnings Summary

VOR is expected to report earnings on 5/12/2026. The consensus EPS estimate for the next earnings is -0.77 USD and the consensus revenue estimate is 0 USD.

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
VOR revenue by date.VOR revenue by date.
N/AN/AN/AN/A
1,004.62%
N/A
129.30%
N/A
127.91%
N/A
-1.02%
N/A
25.24%
EBITDA
YoY % growth
VOR ebitda by date.VOR ebitda by date.
-2.84M-10.33M
-263.73%
-42.76M
-313.94%
-67.59M
-58.07%
-90.89M
-34.47%
-122.544M
-34.83%
-117.657M
3.99%
-339.049M
-188.17%
N/A
52.75%
N/A
-30.54%
N/A
-22.87%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
VOR ebit by date.VOR ebit by date.
-2.86M-10.42M
-264.34%
-43.37M
-316.22%
-69.02M
-59.14%
-93.42M
-35.35%
-126.036M
-34.91%
-121.185M
3.85%
-341.936M
-182.16%
N/A
54.76%
N/A
-44.78%
N/A
16.06%
N/A
18.40%
N/A
118.45%
N/A
1,784.82%
N/A
8.04%
N/A
56.05%
Operating Margin
VOR operating margin by date.VOR operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
VOR eps by date.VOR eps by date.
N/AN/AN/A-43.00
85.44%
-46.80
-8.84%
-35.20
24.79%
-34.00
3.41%
-26.49
22.09%
N/A
83.73%
N/A
-0.82%
N/A
-24.55%
N/A
64.07%
N/A
125.19%
N/A
625.77%
N/A
153.69%
N/A
28.84%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.77
85.22%
-1.04
97.62%
-1.11
66.57%
-1.25
-104.82%
-2.05
-166.84%
-2.29
-119.61%
-2.35
-111.41%
-2.11
-69.49%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
-36.581M
-12.68%
-37.822M
86.07%
-39.366M
-55.95%
-42.821M
-29.47%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-35.763M
-7.42%
-38.224M
86.06%
-40.378M
-43.66%
-44.576M
-23.96%
-77.77M
-117.46%
-87.87M
-129.88%
-91.91M
-127.63%
-84.84M
-90.33%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

VOR Yearly Revenue VS EstimatesVOR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 2029 2030 2031 2032 2033 500M 1B
VOR Yearly EPS VS EstimatesVOR Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -100 -200

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
21.55%
EPS Next 5 Year
15.08%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
9.28%
EBIT Next 5 Year
N/A

VOR BIOPHARMA INC / VOR Forecast FAQ

Can you provide the average price target for VOR BIOPHARMA INC stock?

13 analysts have analysed VOR and the average price target is 38.38 USD. This implies a price increase of 131.33% is expected in the next year compared to the current price of 16.59.

What is the next earnings date for VOR stock?

VOR BIOPHARMA INC (VOR) will report earnings on 2026-05-12.

What are the consensus estimates for VOR stock next earnings?

The consensus EPS estimate for the next earnings of VOR BIOPHARMA INC (VOR) is -0.77 USD and the consensus revenue estimate is 0 USD.